benign prostatic hyperplasia.

March 24, 2017March 24, 2017

Older BPH Patients on Avodart and Similar Drugs at Risk for Self-Harm, Depression — But Not Suicide

News

Older men taking a 5α-reductase inhibitor (5ARI) such as Avodart (dutasteride) and Proscar (finasteride) for prostate enlargement are “significantly” more likely to hurt themselves and suffer from depression — but not ... Read more

August 22, 2016August 22, 2016

Powder Treatment for BPH, Tamsulosin DRS, to Get Speedy FDA Review

News

Aspen Park Pharmaceuticals (APP) announced that the U.S. Food and Drug Administration (FDA) has agreed to an expedited regulatory review process for Tamsulosin DRS, the pharmaceutical’s lead powder formulation of the widely ... Read more

July 25, 2016July 25, 2016

Duodart, a Fixed-Dose Combo Therapy for BPH, Found Most Cost Effective in Nigerian Study

News

A cost-effectiveness analysis of treatments for moderate to severe benign prostatic hyperplasia (BPH) in Nigeria, done from perspective of the social health service provider, favored the fixed-dose combination of dutasteride and tamsulosin therapy over dutasteride monotherapy. ... Read more

June 24, 2016

Bipolar TUEP Is Superior to PVP in Treating BPH Patients, Researchers in China Report

News

Two surgical means of treating benign prostatic hyperplasia (BPH) — bipolar transurethral enucleation of the prostate (TUEP) and photoselective vaporization of the prostate (PVP, a new approach) — were compared in a ... Read more

April 22, 2016

Rezūm Uses Steam to Shrink the Prostate in BPH Patients

In this video from Urology San Antonio, we’re shown how Rezūm therapy uses steam to shrink the prostate in BPH patients, eliminating the need for continuous medications or selective and ... Read more

October 19, 2015October 19, 2015

NICE Report Makes NeoTract’s UroLift System Availability More Likely for BPH Patients in UK

News

NeoTract, Inc., a company dedicated to developing innovative, minimally invasive and clinically effective devices to address unmet needs in the field of urology, has recently welcomed the September announcement by the National ... Read more

October 16, 2015October 16, 2015

Antidepressant Improves Quality of Life in Elderly Patients With BPH and Depression

News

Findings from a recent study published in the International Journal of Clinical and Experimental Medicine suggest that an antidepression medication should be included in the treatment of elderly patients with ... Read more

October 2, 2015October 2, 2015

Medifocus Announces Approach of 100,000 Prolieve(R) Treatments for Benign Prostatic Hyperplasia

News

Medifocus, Inc., a biotechnology company that uses heat-activation to treat diseases ranging from urological problems to breast cancer, recently announced that almost 100,000 men with Benign Prostatic Hyperplasia (BPH) have ... Read more

October 1, 2015October 1, 2015

Researchers Determine Lower Urinary Tract Symptoms Among Men Who Have Sex With Men

News

Prevalence and severity of lower urinary tract symptoms (LUTS) according to male sexual orientation remains poorly investigated. In a recent study published in Nature Prostate Cancer and Prostatic Diseases , ... Read more

September 24, 2015September 24, 2015

Researchers Find Positive Association Between Air Pollution Benign Prostatic Hyperplasia Risk

News

Results from a recent study published in the Archives of Environmental & Occupational Health, support a positive association between the risk of developing benign prostatic hyperplasia (BPH) and air pollution. BPH refers ... Read more